Insider · CIK 0001197350
Eric Bjerkholt
Files at CERS (CERUS CORP), MIRM (Mirum Pharmaceuticals, Inc.), MGX (Metagenomi, Inc.), SRZN (Surrozen, Inc./DE). First filing Dec 16, 2024, latest Sep 15, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
MIRM: Mirum Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CERS: CERUS CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Mirum Pharmaceuticals, Inc. | $978k 9,943 shares | -18% | - | |
| 34Weak | CERUS CORP | $36k 20,000 shares | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +18,333 | - | - | 54,688 | 27 d ago |
| Sep 14, 2026 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -9,943 | $98.37 | $978k | 44,745 | 27 d ago |
| Sep 11, 2026 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -18,333 | $0.00 | $0 | 0 | 27 d ago |
| Jun 10, 2025 | MGX Metagenomi, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,572 | $0.00 | $0 | 8,572 | Jun 12, 2025 |
| Jun 3, 2025 | CERS CERUS CORP | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 222,133 | Jun 4, 2025 |
| May 14, 2025 | SRZN Surrozen, Inc./DE | AGrant or award Option (right to buy)derivative | +1,333 | $0.00 | $0 | 1,333 | May 15, 2025 |
| Feb 3, 2025 | MGX Metagenomi, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +42,000 | $0.00 | $0 | 42,000 | Feb 5, 2025 |
| Jan 23, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +2,667 | - | - | 35,946 | Jan 27, 2025 |
| Jan 23, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,667 | $0.00 | $0 | 5,333 | Jan 27, 2025 |
| Jan 21, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 23, 2025 |
| Jan 21, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +10,000 | $0.00 | $0 | 10,000 | Jan 23, 2025 |
| Dec 12, 2024 | CERS CERUS CORP | SOpen-market sale Common Stock | -20,000 | $1.79 | $36k | 162,133 | Dec 16, 2024 |
| Nov 8, 2024 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Common Stock | +475 | $21.05 | $9,997 | 33,279 | Nov 14, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.